Safety of natalizumab reinfusion during active Sars-Cov-2 infection in patients with multiple sclerosis

被引：0
|
作者：
Landi, D. [1 ]
Cola, G. [1 ]
Mantero, V. [2 ]
Balgera, R. [2 ]
Moiola, L. [3 ]
Nozzolillo, A. [3 ]
Dattola, V. [4 ]
Sinisi, L. [5 ,6 ]
Fantozzi, R. [7 ]
Centonze, D. [7 ,8 ]
Mataluni, G. [1 ]
Nicoletti, C. G. [1 ]
Marfia, A. G. [1 ,7 ]
机构：
[1] Univ Roma Tor Vergata, Dept Syst Med, Multiple Sclerosis Clin & Res Unit, Rome, Italy
[2] ASST Lecco, MS Ctr, Lecce, Italy
[3] San Raffaele Hosp IRCCS, MS Ctr, Dept Neurol, Milan, Italy
[4] Grande Osped Metropolitano Bianchi Melacrino More, UOC Neurol, Reggio Di Calabria, Italy
[5] San Paolo Hosp ASL Napoli 1 Ctr, Neurol Unit, Naples, Italy
[6] San Paolo Hosp ASL Napoli 1 Ctr, MS Ctr, Naples, Italy
[7] IRCCS Neuromed, Neurol Unit, Pozzilli, Italy
[8] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P769
引用
收藏
页码：641 / 641
页数：1
相关论文
共 50 条
  • [31] Humoral response to SARS-CoV-2 natural Infection and mRNA vaccines among patients with multiple sclerosis
    Jaber, A.
    Greco, C.
    Sylvester, A.
    Tremblay, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 574 - 574
  • [32] Sars-cov-2 infection in multiple sclerosis patients: a single center experience in the province of bergamo, italy
    Radaelli, M.
    Barcella, V.
    Conti, M.
    Sessa, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 321 - 321
  • [33] SARS-COV-2 infection impact on patients with multiple sclerosis and neuromyelitis spectrum disorder in a Colombia cohort
    Cardona, P.
    Jimenez, J.
    Franco, C. A.
    Tobon, J. V.
    Munoz, N. L.
    Restrepo-Aristizabal, C.
    Rodriguez-Marquez, I.
    Zuluaga, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 322 - 322
  • [34] Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain)
    Castillo Alvarez, Federico
    Lopez Perez, Ma Angeles
    Marzo Sola, Maria Eugenia
    MEDICINA CLINICA, 2020, 155 (08): : 362 - 363
  • [35] Efficacy of SARS-CoV-2 vaccination in Multiple Sclerosis
    Gyang, T. V.
    Evans, J.
    Miller, J.
    Alcorn, K.
    Peng, J.
    Bell, E.
    Zeng, C.
    Gumina, R.
    Liu, S.
    Segal, B. M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 80 - 80
  • [36] SARS-CoV-2 triggered relapse of multiple sclerosis
    Finsterer, Josef
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 215
  • [37] EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic
    Costa-Frossard, Lucienne
    Moreno-Torres, Irene
    Meca-Lallana, Virginia
    Garcia-Dominguez, Jose M.
    REVISTA DE NEUROLOGIA, 2020, 70 (09) : 329 - 340
  • [38] SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
    Sgherza, Nicola
    Curci, Paola
    Rizzi, Rita
    Attolico, Immacolata
    Loconsole, Daniela
    Mestice, Anna
    Chironna, Maria
    Musto, Pellegrino
    BLOOD CANCER JOURNAL, 2021, 11 (12)
  • [39] SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
    Nicola Sgherza
    Paola Curci
    Rita Rizzi
    Immacolata Attolico
    Daniela Loconsole
    Anna Mestice
    Maria Chironna
    Pellegrino Musto
    Blood Cancer Journal, 11
  • [40] Safety of a third SARS-CoV-2 mRNA vaccine dose in people with multiple sclerosis
    Rasmussen, T. H.
    Konig, M.
    Lorentzen, A. R.
    Schikora-Rustad, S.
    Berge, T.
    Holmoy, T.
    Torkildsen, O.
    Wergeland, S.
    Overas, M. H.
    Hogestol, E. A.
    Torgauten, H. M.
    Harbo, H. F.
    Celius, E. G.
    Munthe, L. A.
    Vaage, J. T.
    Johansen, F. L.
    Nygaard, G. O.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 480 - 481
12345